Vizsgálati helyszín
Taipei Municipal Wan Fang Hospital
Taipei, 116, TajvanMég nincs intézményhez kötve
Az itteni vizsgálatok
Miről szól a helyszín 12 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis6 vizsgálat
- 2. fázis2 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Toboroz7 vizsgálat
- Fut, nem toboroz5 vizsgálat
- Fő szponzor
- Regeneron Pharmaceuticals6 vizsgálat
- PharmaEssentia2 vizsgálat
- National Taiwan University Hospital1 vizsgálat
- Pfizer1 vizsgálat
- Taipei Medical University1 vizsgálat
- és még 1
Futó vizsgálatok
Toboroz
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033· 3. fázis· PharmaEssentia· Forrás
Toboroz
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
NCT06787612· 2. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
NCT06292780· 1/2. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
NCT06161441· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
NCT06149286· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
NCT06091254· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
NCT05654623· 3. fázis· Pfizer· Forrás
Toboroz
Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation
NCT05492175· Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation· Forrás
Contact: Keh-Chung Lin, ScD
Fut, nem toboroz
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086· 3. fázis· PharmaEssentia· Forrás
Toboroz
Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke
NCT04446273· National Taiwan University Hospital· Forrás
Contact: Han-Ting Tsai, MS
Fut, nem toboroz
Enhancing Community Participation for Stroke Survivors With Cognitive Impairments
NCT03792061· Taipei Medical University· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek